enfuvirtide, T-20 (Fuzeon)

Type of Drug: Fusion Inhibitor

Fusion inhibitors work by stopping the HIV virus from getting into your body's healthy cells in the first place.

Approved adult dosing

90 mg (in 1 mL solution) injection

one injection under the skin, two times a day

  • Morning

Picture of Fuzeon (enfuvirtide, T-20) injection medication for the treatment of HIV

Fuzeon

  • Evening
Picture of Fuzeon (enfuvirtide, T-20) injection medication for the treatment of HIV

Fuzeon

Notes on taking this medication

  • One vial contains a white powder, which is the medication (Fuzeon); another vial contains sterile water; withdraw the water with a syringe and mix into the vial with the Fuzeon
  • You can prepare both doses at the same time, but should store the second vial in a refrigerator for use later on the same day
  • Keep uncapped vial tops, syringes, and your hands clean while preparing Fuzeon
  • Draw Fuzeon solution into the syringe only when you are ready to inject
  • Rotate injection sites for each injection
  • Never inject Fuzeon into a vein or muscle

Side effects

  • At injection site: redness; pain or tenderness; swelling; bumps; hardening of skin
  • Very rare serious allergic reactions: symptoms include trouble breathing; fever with vomiting and rash; swollen feet

SOURCE: United States Department of Veterans Affairs. "Drug Dosing Toolkit, Fuzeon (enfuvirtide, T-20)."
<http://www.hiv.va.gov/vahiv?page=treat-drug-Fuzeon>


Last Editorial Review: 2/5/2010 2:22:24 PM




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index